Copyright
©The Author(s) 2016.
World J Gastroenterol. May 14, 2016; 22(18): 4484-4500
Published online May 14, 2016. doi: 10.3748/wjg.v22.i18.4484
Published online May 14, 2016. doi: 10.3748/wjg.v22.i18.4484
Figure 7 Diarylpropionitrile inhibits collagen lattice contraction in hepatic stellate cells and decreases ET-1 induced moesin and MLC phosphorylation.
A: Appearance of collagen lattices 4 h after drug treatment; B: The percentage of remaining lattice area 4 h after drug treatment (each group n = 12); C, D: Western blot analysis of ERβ protein expression in hepatic stellate cells (HSCs) (each group n = 5); E: Western blot analysis of the total and phosphorylated moesin and MLC in HSCs; F: Relative densitometric quantifications of moesin and MLC experiments (mean ± SE), with the values of the controls set to 100 DU (each group n = 5). aP < 0.05 vs control group; cP < 0.05 vs DPN group. OVX: ovariectomized; SVR: Systemic vascular resistance; DPN: Diarylpropionitrile.
- Citation: Zhang CG, Zhang B, Deng WS, Duan M, Chen W, Wu ZY. Role of estrogen receptor β selective agonist in ameliorating portal hypertension in rats with CCl4-induced liver cirrhosis. World J Gastroenterol 2016; 22(18): 4484-4500
- URL: https://www.wjgnet.com/1007-9327/full/v22/i18/4484.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i18.4484